Overview

A Study of the Electrocardiogram Effects and Pharmacokinetics of Ferumoxytol in Healthy Men and Women

Status:
Completed
Trial end date:
2006-08-01
Target enrollment:
Participant gender:
Summary
This study will define the effects of ferumoxytol on electrocardiogram (ECG) data as well as evaluate pharmacokinetics
Phase:
Phase 1
Details
Lead Sponsor:
AMAG Pharmaceuticals, Inc.
Treatments:
Ferrosoferric Oxide
Moxifloxacin